Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Timken (TKR) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Timken (TKR) over the last 17 years, with Q3 2025 value amounting to $449.1 million.

  • Timken's Cash & Equivalents rose 882.0% to $449.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $449.1 million, marking a year-over-year increase of 882.0%. This contributed to the annual value of $373.2 million for FY2024, which is 1090.95% down from last year.
  • Timken's Cash & Equivalents amounted to $449.1 million in Q3 2025, which was up 882.0% from $419.3 million recorded in Q2 2025.
  • In the past 5 years, Timken's Cash & Equivalents registered a high of $469.9 million during Q2 2024, and its lowest value of $257.1 million during Q4 2021.
  • For the 5-year period, Timken's Cash & Equivalents averaged around $361.7 million, with its median value being $367.9 million (2023).
  • Per our database at Business Quant, Timken's Cash & Equivalents plummeted by 2649.18% in 2021 and then skyrocketed by 4042.34% in 2022.
  • Over the past 5 years, Timken's Cash & Equivalents (Quarter) stood at $257.1 million in 2021, then increased by 28.98% to $331.6 million in 2022, then increased by 26.33% to $418.9 million in 2023, then fell by 10.91% to $373.2 million in 2024, then grew by 20.34% to $449.1 million in 2025.
  • Its Cash & Equivalents stands at $449.1 million for Q3 2025, versus $419.3 million for Q2 2025 and $376.1 million for Q1 2025.